Alkyl Amines Chemicals Limited (ALKYLAMINE.BO)
INR 1937.6
(0.25%)
INR 1937.6
(0.25%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.71 Billion | 2.48 Billion | 2.04 Billion | 3.63 Billion | 1.88 Billion | 1.44 Billion |
| Net Income | 1.48 Billion | 3.08 Billion | 3.02 Billion | 4 Billion | 2.59 Billion | 1.32 Billion |
| Depreciation & Amortization | 589.2 Million | 451.73 Million | 347.52 Million | 290.63 Million | 269.09 Million | 233.36 Million |
| Deferred income taxes | - | -660.69 Million | -775.89 Million | -1 Billion | -879.97 Million | -335.78 Million |
| Stock-based compensation | 11 Million | 13.2 Million | 17.77 Million | 19.24 Million | 8.49 Million | 10.31 Million |
| Change in working capital | 403 Million | -427.44 Million | -568.47 Million | 289.57 Million | -193.49 Million | 64.12 Million |
| Other non-cash items | 1.1 Billion | 21.43 Million | 4.68 Million | 36.67 Million | 84.58 Million | 144.52 Million |
| Investing Cash Flow | -1.22 Billion | -2.77 Billion | -2.05 Billion | -2.12 Billion | -406.83 Million | -667.88 Million |
| Investments in PPE | -1.22 Billion | -3.03 Billion | -2.46 Billion | -1.56 Billion | -772.84 Million | -690.43 Million |
| Acquisitions | 2.7 Million | 4.43 Million | 7.89 Million | 979 Thousand | 1.54 Million | 15.53 Million |
| Investment purchases | -2.9 Million | -214.43 Million | -200 Million | -299.98 Million | -1.9 Million | 4.53 Million |
| Sales/Maturities of investments | - | 236.85 Million | 517.23 Million | 21.1 Million | 342.82 Million | 923 Thousand |
| Other Investing Activities | -2.9 Million | 236.85 Million | 87.71 Million | -286.92 Million | 23.54 Million | 1.56 Million |
| Financing Cash Flow | -1.35 Billion | 79.91 Million | -572.89 Million | -864.51 Million | -1.35 Billion | -603.15 Million |
| Debt repayment | -848.4 Million | -736.22 Million | -227.59 Million | -381.16 Million | -797.04 Million | -345.62 Million |
| Dividends payments | -511.13 Million | -510.91 Million | -306.37 Million | -416.88 Million | -453.74 Million | -172.12 Million |
| Common Stock Repurchased | - | - | -41.75 Million | -70.16 Million | - | - |
| Common Stock Issuance | 8.19 Million | 12.39 Million | 6.96 Million | 3.69 Million | - | - |
| Other Financing Activities | 8.1 Million | 1.31 Billion | -4.14 Million | -8.79 Million | -120.31 Million | -85.4 Million |
| Accounts receivables | 365.3 Million | 183.13 Million | -487.58 Million | -637.66 Million | -148.99 Million | -348.55 Million |
| Accounts payables | -178.2 Million | -387.52 Million | 523.23 Million | 1.08 Billion | -532.15 Million | 568.1 Million |
| Inventory | 117 Million | -191.33 Million | -426.32 Million | -382.31 Million | 220.27 Million | -205.11 Million |
| Other working capital | 98.9 Million | -31.71 Million | -177.79 Million | 220.15 Million | 267.37 Million | 49.68 Million |
| Cash at beginning of period | 182.32 Million | 378.63 Million | 961.44 Million | 312.38 Million | 193.39 Million | 22.34 Million |
| Cash at end of period | 313.7 Million | 171.85 Million | 378.63 Million | 961.44 Million | 312.38 Million | 193.39 Million |
| Capital Expenditure | -1.22 Billion | -3.03 Billion | -2.46 Billion | -1.56 Billion | -772.84 Million | -690.43 Million |
| Effect of forex changes on cash | - | - | - | - | - | 1000.00 |
| Net cash flow / Change in cash | 131.37 Million | -206.78 Million | -582.8 Million | 649.05 Million | 118.99 Million | 171.04 Million |
| Free Cash Flow | 1.49 Billion | -550.4 Million | -422.75 Million | 2.07 Billion | 1.11 Billion | 751.65 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.48 Billion | 334.3 Million | 272.4 Million | 497.7 Million | 3.08 Billion | 486.4 Million |
| Depreciation & Amortization | 589.2 Million | 167.8 Million | 125.3 Million | 121.8 Million | 451.73 Million | 115.9 Million |
| Deferred income taxes | - | - | - | - | -660.69 Million | - |
| Stock-based compensation | 11 Million | - | - | - | 13.2 Million | - |
| Change in working capital | 403 Million | - | - | - | -427.44 Million | - |
| Other non-cash items | 1.1 Billion | -167.8 Million | -125.3 Million | -121.8 Million | 21.43 Million | -115.9 Million |
| Investing Cash Flow | -1.22 Billion | - | - | - | -2.77 Billion | - |
| Investments in PPE | -1.22 Billion | - | - | - | -3.03 Billion | - |
| Acquisitions | 2.7 Million | - | - | - | 4.43 Million | - |
| Investment purchases | -2.9 Million | - | - | - | -214.43 Million | - |
| Sales/Maturities of investments | - | - | - | - | 236.85 Million | - |
| Other Investing Activities | -2.9 Million | - | - | - | 236.85 Million | - |
| Financing Cash Flow | -1.35 Billion | - | - | - | 79.91 Million | - |
| Debt repayment | -848.4 Million | - | - | - | -736.22 Million | - |
| Dividends payments | -511.13 Million | - | - | - | -510.91 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 8.19 Million | - | - | - | 12.39 Million | - |
| Other Financing Activities | 8.1 Million | - | - | - | 1.31 Billion | - |
| Accounts receivables | 365.3 Million | - | - | - | 183.13 Million | - |
| Accounts payables | -178.2 Million | - | - | - | -387.52 Million | - |
| Inventory | 117 Million | - | - | - | -191.33 Million | - |
| Other working capital | 98.9 Million | - | - | - | -31.71 Million | - |
| Cash at beginning of period | 182.32 Million | 154.5 Million | -117.9 Million | 182.32 Million | 378.63 Million | -304.07 Million |
| Cash at end of period | 313.7 Million | 334.3 Million | 154.5 Million | 497.7 Million | 171.85 Million | 182.32 Million |
| Capital Expenditure | -1.22 Billion | - | - | - | -3.03 Billion | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 131.37 Million | 179.8 Million | 272.4 Million | 315.37 Million | -206.78 Million | 486.4 Million |
| Free Cash Flow | 1.49 Billion | 334.3 Million | 272.4 Million | 497.7 Million | -550.4 Million | 486.4 Million |
LAURUSLABS
EVERFIN
SRICHA
GULFPETRO
1897
SANGHVIMOV